INSMInsmed IncorporatedDowntrendEarnings in 2 days

TodayDowntrendnormal stock

Nasdaq GSBiotechnologyMarket cap $20.38BReports Oct 29, 2026

Insmed Incorporated

Rare disease
Sector
Healthcare
Industry
Biotechnology
Market cap
$20.38B
Employees
1,664
Exchange
Nasdaq GS
Country
United States
Website
insmed.com
93.33−0.06% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Downtrend, stage 4 of 4, 3 of 4 damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading below its key moving averages and momentum readings are washed out: recent selling pressure has been heavy. RSI is currently 28.

Readings, end-of-day Oct 26, 2026
RSI (14)Oversold zone28.20, flagged reading
MACD / signalBelow signal line-6.14 / -6.02, caution reading
SMA 50Price below114.59, caution reading
SMA 200Price below126.69, caution reading
EMA 20Price below100.96, caution reading
ADX (14)Trending46.93
Show all 12 readings
+DI / −DI−DI leading8.20 / 31.17, caution reading
ATR (14)3.1% of price — typical daily swing2.90
Stochastic %KOversold zone5.75, flagged reading
Bollinger bands (20)Inside bands87.12 – 114.56
ROC (10)Negative over 10 sessions-5.31, caution reading
Trend / momentum impulseTrend and momentum disagreeMixed
Full analysis

What unlocking INSM reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when INSM's analysis runs, rather than checked against its stored data now.

Every section above, argued on INSM's own numbers, on one page.

See what INSM costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full INSM analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get INSM + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does Insmed Incorporated report earnings?

Insmed Incorporated (INSM) is scheduled to report earnings on Oct 29, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock INSM